Diagnostic and Prognostic Utility of the Extracellular Vesicles Subpopulations Present in Pleural Effusion

被引:18
作者
Javadi, Joman [1 ]
Goergens, Andre [2 ]
Vanky, Hanna [1 ]
Gupta, Dhanu [2 ]
Hjerpe, Anders [1 ]
EL-Andaloussi, Samir [2 ]
Hagey, Daniel [2 ]
Dobra, Katalin [1 ]
机构
[1] Karolinska Inst, Div Pathol, Dept Lab Med, S-14152 Stockholm, Sweden
[2] Karolinska Inst, Div BCM, Dept Lab Med, S-14152 Stockholm, Sweden
关键词
malignant pleural mesothelioma; pleural effusion; extracellular vesicles; biomarkers; CYTOPATHOLOGIC DIAGNOSIS; TUMOR PROGRESSION; EXOSOMES; MESOTHELIOMA; MICROVESICLES; GUIDELINES; SECRETION; STATEMENT; GALECTINS; UPDATE;
D O I
10.3390/biom11111606
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Extracellular vesicles (EVs), comprising exosomes, microvesicles, and apoptotic bodies, are released by all cells into the extracellular matrix and body fluids, where they play important roles in intercellular communication and matrix remodeling in various pathological conditions. Malignant pleural mesothelioma (MPM) is a primary tumor of mesothelial origin, predominantly related to asbestos exposure. The detection of MPM at an early stage and distinguishing it from benign conditions and metastatic adenocarcinomas (AD) is sometimes challenging. Pleural effusion is often the first available biological material and an ideal source for characterizing diagnostic and prognostic factors. Specific proteins have previously been identified as diagnostic markers in effusion, but it is not currently known whether these are associated with vesicles or released in soluble form. Here, we study and characterize tumor heterogeneity and extracellular vesicle diversity in pleural effusion as diagnostic or prognostic markers for MPM. We analyzed extracellular vesicles and soluble proteins from 27 pleural effusions, which were collected and processed at the department of pathology and cytology at Karolinska University Hospital, representing three different patient groups, MPM (n = 9), benign (n = 6), and AD (n = 12). The vesicles were fractionated into apoptotic bodies, microvesicles, and exosomes by differential centrifugation and characterized by nanoparticle tracking analysis and Western blotting. Multiplex bead-based flow cytometry analysis showed that exosomal markers were expressed differently on EVs present in different fractions. Further characterization of exosomes by a multiplex immunoassay (Luminex) showed that all soluble proteins studied were also present in exosomes, though the ratio of protein concentration present in supernatant versus exosomes varied. The proportion of Angiopoietin-1 present in exosomes was generally higher in benign compared to malignant samples. The corresponding ratios of Mesothelin, Galectin-1, Osteopontin, and VEGF were higher in MPM effusions compared to those in the benign group. These findings demonstrate that relevant diagnostic markers can be recovered from exosomes.
引用
收藏
页数:15
相关论文
共 42 条
[1]   Intercellular transfer of the oncogenic receptor EGFrvIII by microvesicles derived from tumour cells [J].
Al-Nedawi, Khalid ;
Meehan, Brian ;
Micallef, Johann ;
Lhotak, Vladimir ;
May, Linda ;
Guha, Abhijit ;
Rak, Janusz .
NATURE CELL BIOLOGY, 2008, 10 (05) :619-U24
[2]  
Carnell-Morris P, 2017, METHODS MOL BIOL, V1660, P153, DOI 10.1007/978-1-4939-7253-1_13
[3]   Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking Analysis [J].
Dragovic, Rebecca A. ;
Gardiner, Christopher ;
Brooks, Alexandra S. ;
Tannetta, Dionne S. ;
Ferguson, David J. P. ;
Hole, Patrick ;
Carr, Bob ;
Redman, Christopher W. G. ;
Harris, Adrian L. ;
Dobson, Peter J. ;
Harrison, Paul ;
Sargent, Ian L. .
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2011, 7 (06) :780-788
[4]   Co-Expression of Mesothelin and CA125 Correlates With Unfavorable Patient Outcome in Pancreatic Ductal Adenocarcinoma [J].
Einama, Takahiro ;
Kamachi, Hirofumi ;
Nishihara, Hiroshi ;
Homma, Shigenori ;
Kanno, Hiromi ;
Takahashi, Kenta ;
Sasaki, Ayami ;
Tahara, Munenori ;
Okada, Kuniaki ;
Muraoka, Shunji ;
Kamiyama, Toshiya ;
Matsuno, Yoshihiro ;
Ozaki, Michitaka ;
Todo, Satoru .
PANCREAS, 2011, 40 (08) :1276-1282
[5]   Extracellular vesicles: biology and emerging therapeutic opportunities [J].
EL Andaloussi, Samir ;
Maeger, Imre ;
Breakefield, Xandra O. ;
Wood, Matthew J. A. .
NATURE REVIEWS DRUG DISCOVERY, 2013, 12 (05) :348-358
[6]   Altered Extracellular Vesicle Concentration, Cargo, and Function in Diabetes [J].
Freeman, David W. ;
Noren Hooten, Nicole ;
Eitan, Erez ;
Green, Jamal ;
Mode, Nicolle A. ;
Bodogai, Monica ;
Zhang, Yongqing ;
Lehrmann, Elin ;
Zonderman, Alan B. ;
Biragyn, Arya ;
Egan, Josephine ;
Becker, Kevin G. ;
Mattson, Mark P. ;
Ejiogu, Ngozi ;
Evans, Michele K. .
DIABETES, 2018, 67 (11) :2377-2388
[7]   MONONUCLEAR-CELLS IN EXUDATIVE MALIGNANT PLEURAL EFFUSIONS - CHARACTERIZATION OF PLEURAL PHAGOCYTIC-CELLS [J].
GJOMARKAJ, M ;
PACE, E ;
MELIS, M ;
SPATAFORA, M ;
TOEWS, GB .
CHEST, 1994, 106 (04) :1042-1049
[8]   Proteomic insights into extracellular vesicle biology - defining exosomes and shed microvesicles [J].
Greening, David W. ;
Xu, Rong ;
Gopal, Shashi K. ;
Rai, Alin ;
Simpson, Richard J. .
EXPERT REVIEW OF PROTEOMICS, 2017, 14 (01) :69-95
[9]   Autologous tumor cell-derived microparticle-based targeted chemotherapy in lung cancer patients with malignant pleural effusion [J].
Guo, Mengfei ;
Wu, Feng ;
Hu, Guorong ;
Chen, Lian ;
Xu, Juanjuan ;
Xu, Pingwei ;
Wang, Xuan ;
Li, Yumei ;
Liu, Shuqing ;
Zhang, Shuai ;
Huang, Qi ;
Fan, Jinshuo ;
Lv, Zhilei ;
Zhou, Mei ;
Duan, Limin ;
Liao, Tingting ;
Yang, Guanghai ;
Tang, Ke ;
Liu, Bifeng ;
Liao, Xiaofei ;
Tao, Xiaonan ;
Jin, Yang .
SCIENCE TRANSLATIONAL MEDICINE, 2019, 11 (474)
[10]   Extracellular vesicles are the primary source of blood-borne tumour-derived mutant KRAS DNA early in pancreatic cancer [J].
Hagey, Daniel W. ;
Kordes, Maximilian ;
Gorgens, Andre ;
Mowoe, Metoboroghene O. ;
Nordin, Joel Z. ;
Moro, Carlos Fernandez ;
Lohr, J-Matthias ;
El Andaloussi, Samir .
JOURNAL OF EXTRACELLULAR VESICLES, 2021, 10 (12)